In a new study led by UCLA Jonsson Comprehensive Cancer Center member Dr. Roger Lo, researchers have uncovered how melanoma becomes resistant to a promising new drug combo therapy utilizing BRAF+MEK inhibitors in patients after an initial period of tumor shrinkage.
from The Medical News http://ift.tt/14IRZ8E
from The Medical News http://ift.tt/14IRZ8E
No comments:
Post a Comment